eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
ChemoSen↑, eff↑, RadioS↑, CEA↓, Wnt↓, β-catenin/ZEB1↓, γH2AX↑, ER Stress↑, mt-TumAuto↑, QoL↑, Imm↑,
| - |
in-vitro, |
GBM, |
U251 |
|
|
|
- |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vitro, |
GBM, |
GL26 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
CRC, |
RKO |
|
|
|
AntiCan↑, eff↑, EPR↑, selectivity↑, ROS↑, Casp↑, Apoptosis↑, DNAdam↑, tumCV↓, eff↑,
Apoptosis↑, ChrMod↝, eff↑,
APA↑, p62↓, PIK3CA↑, TumVol↓, TumAuto↑, eff↑,
eff↝, TumCCA↑, eff↑, eff↑, ROS↑, GSH↓, SOD↓, lipid-P↑, LDH↑,
TumCD↑, eff↑, TumAuto↑, ER Stress↑, Paraptosis↑, GRP78/BiP↓, Dose↝,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
Dose↝, TumCMig↓, Apoptosis↑, necrosis↑, ROS↑, eff↑,
| - |
in-vitro, |
Cerv, |
CCL-102 |
|
|
|
Inflam↓, AntiTum↑, Proteasome↓, ER Stress↑, HSPs↑, GRP94↑, Akt↑, eff↑, HSP70/HSPA5↑,
GLS↓, NADPH↓, ROS↑, TumCD↑, AMPK↑, Hif1a↓, GLUT1↓, GLUT3↓, HK2↓, PFK↓, PKM2↓, LDH↓, cMyc↓, BAX↓, cycD1/CCND1↓, PDH↓, ROS↑, Apoptosis↑, eff↑, ACLY↓, FASN↓, Bcl-2↓, Glycolysis↓,
eff↑, ROS↑, Casp8↓, Casp9↑, BAX↑, Cyt‑c↑, Bcl-2↓, AKT1↓,
eff↑, Dose∅, ROS↑, DNAdam↑, P53↑, P21↑, BAX↑, Dose∅,
TrxR1↓, ROS↑, DNA-PK↑, eff↑, Trx↓, Trx1↓,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
TrxR↓, Dose↝, eff↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
HUVECs |
|
|
|
eff↑, Dose∅, *BioAv↑, selectivity↑, TumCP↓, Casp↑, PTEN↑, TSC1↑, mTOR⇅, Akt↓, PDK1↓, E6↓, E7↓, DNAdam↑, ROS↑, *BioAv↓, *BioEnh↑, *Half-Life∅,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
HCC, |
QGY-7703 |
|
|
|
PARP16↓, p‑PERK↓, Apoptosis↑, eIF2α↓, UPR↓, ER Stress↑, eff↑, GRP78/BiP↓,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
selectivity↑, *toxicity∅, TumCG↓, NADHdeh?, eff↑, ENOX2↓, Dose?,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
- |
in-vitro, |
BC, |
BT20 |
|
|
|
selectivity↑, ENOX2↓, NADH↑, SK↓, eff↑, aSmase↑,
| - |
in-vitro, |
AML, |
THP1 |
|
|
|
- |
in-vitro, |
NA, |
PC12 |
|
|
|
- |
in-vivo, |
Cerv, |
HeLa |
|
|
|
H2O2↑, TumCD↑, CellMemb↑, eff↑,
eff↑, tumCV↓,
AntiCan↑, TrxR1↓, TrxR2↓, ROS↑, Apoptosis↑, eff↓, eff↑,
eff↑, TrxR↓, ROS↑, RadioS↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
LLC1 |
|
|
|
eff↑, tumCV↓, ATP↓, ROS↑, Casp3↑, Casp7↑, mtDam↑,
TumCP↓, PI3K↓, Akt↓, mTOR↓, eff↑, ROS↑,
| - |
in-vivo, |
Cerv, |
HeLa |
|
|
|
- |
in-vivo, |
Cerv, |
SiHa |
|
|
|
TumCG↓, toxicity↓, tumCV↓, Apoptosis↑, p‑PI3K↓, p‑Akt↓, eff↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
eff↑, ROS↑,
eff↑, ROS↑, tumCV↓, TumCG↓, Apoptosis↑, cl‑Casp3↑, cl‑Casp9↑, Bcl-xL↑, Cyt‑c↑, Bcl-2↓,
Showing Research Papers: 1 to 26 of 26
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 26
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ENOX2↓, 2, GSH↓, 1, H2O2↑, 1, lipid-P↑, 1, NADH↑, 1, NADHdeh?, 1, ROS↑, 15, SOD↓, 1, Trx↓, 1, Trx1↓, 1, TrxR↓, 2, TrxR1↓, 2, TrxR2↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, mtDam↑, 1,
Core Metabolism/Glycolysis ⓘ
ACLY↓, 1, AKT1↓, 1, AMPK↑, 1, cMyc↓, 1, FASN↓, 1, GLS↓, 1, Glycolysis↓, 1, HK2↓, 1, LDH↓, 1, LDH↑, 1, NADPH↓, 1, PDH↓, 1, PDK1↓, 1, PFK↓, 1, PIK3CA↑, 1, PKM2↓, 1,
Cell Death ⓘ
Akt↓, 2, Akt↑, 1, p‑Akt↓, 1, Apoptosis↑, 8, aSmase↑, 1, BAX↓, 1, BAX↑, 2, Bcl-2↓, 3, Bcl-xL↑, 1, Casp↑, 2, Casp3↑, 1, cl‑Casp3↑, 1, Casp7↑, 1, Casp8↓, 1, Casp9↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 2, necrosis↑, 1, Paraptosis↑, 1, Proteasome↓, 1, SK↓, 1, TumCD↑, 3,
Transcription & Epigenetics ⓘ
ChrMod↝, 1, tumCV↓, 5,
Protein Folding & ER Stress ⓘ
eIF2α↓, 1, ER Stress↑, 4, GRP78/BiP↓, 2, GRP94↑, 1, HSP70/HSPA5↑, 1, HSPs↑, 1, p‑PERK↓, 1, UPR↓, 1,
Autophagy & Lysosomes ⓘ
APA↑, 1, p62↓, 1, TumAuto↑, 2, mt-TumAuto↑, 1,
DNA Damage & Repair ⓘ
DNA-PK↑, 1, DNAdam↑, 3, P53↑, 1, γH2AX↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, P21↑, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
mTOR↓, 1, mTOR⇅, 1, PI3K↓, 1, p‑PI3K↓, 1, PTEN↑, 1, TumCG↓, 3, Wnt↓, 1,
Migration ⓘ
CEA↓, 1, TSC1↑, 1, TumCMig↓, 1, TumCP↓, 2, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature ⓘ
EPR↑, 1, Hif1a↓, 1,
Barriers & Transport ⓘ
CellMemb↑, 1, GLUT1↓, 1, GLUT3↓, 1,
Immune & Inflammatory Signaling ⓘ
Imm↑, 1, Inflam↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, Dose?, 1, Dose↝, 3, Dose∅, 3, eff↓, 1, eff↑, 28, eff↝, 1, RadioS↑, 2, selectivity↑, 4,
Clinical Biomarkers ⓘ
CEA↓, 1, E6↓, 1, E7↓, 1, LDH↓, 1, LDH↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 2, AntiTum↑, 1, PARP16↓, 1, QoL↑, 1, toxicity↓, 1, TumVol↓, 1,
Total Targets: 113
Pathway results for Effect on Normal Cells:
Drug Metabolism & Resistance ⓘ
BioAv↓, 1, BioAv↑, 1, BioEnh↑, 1, Half-Life∅, 1,
Functional Outcomes ⓘ
toxicity∅, 1,
Total Targets: 5
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:961 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page